- Home
- IRON vs HLIO Comparison
IRON vs HLIO Comparison
Compare IRON & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- HLIO
- Stock Information
- Founded
- IRON 2017
- HLIO 1970
- Country
- IRON United States
- HLIO United States
- Employees
- IRON N/A
- HLIO N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- HLIO Metal Fabrications
- Sector
- IRON Health Care
- HLIO Industrials
- Exchange
- IRON Nasdaq
- HLIO Nasdaq
- Market Cap
- IRON 2.0B
- HLIO 1.8B
- IPO Year
- IRON N/A
- HLIO N/A
- Fundamental
- Price
- IRON $60.35
- HLIO $54.23
- Analyst Decision
- IRON Strong Buy
- HLIO Strong Buy
- Analyst Count
- IRON 11
- HLIO 4
- Target Price
- IRON $95.73
- HLIO $44.25
- AVG Volume (30 Days)
- IRON 325.5K
- HLIO 414.8K
- Earning Date
- IRON 08-07-2025
- HLIO 08-04-2025
- Dividend Yield
- IRON N/A
- HLIO 0.67%
- EPS Growth
- IRON N/A
- HLIO 17.55
- EPS
- IRON N/A
- HLIO 1.05
- Revenue
- IRON N/A
- HLIO $782,000,000.00
- Revenue This Year
- IRON N/A
- HLIO N/A
- Revenue Next Year
- IRON N/A
- HLIO $4.75
- P/E Ratio
- IRON N/A
- HLIO $51.41
- Revenue Growth
- IRON N/A
- HLIO N/A
- 52 Week Low
- IRON $30.82
- HLIO $24.76
- 52 Week High
- IRON $68.73
- HLIO $57.29
- Technical
- Relative Strength Index (RSI)
- IRON 57.22
- HLIO 76.80
- Support Level
- IRON $57.54
- HLIO $50.72
- Resistance Level
- IRON $64.83
- HLIO $53.53
- Average True Range (ATR)
- IRON 2.14
- HLIO 1.82
- MACD
- IRON -0.19
- HLIO 0.22
- Stochastic Oscillator
- IRON 46.60
- HLIO 98.08
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness. It derives maximum revenue from the Hydraulics Segment.